BETA

IPO registrations (S-1, F-1) · Registrants

PRECIGEN, INC.

SEC CIK
1356090 · filings on EDGAR ↗
Name on the registration
INTREXON CORP
Former names
INTREXON CORP (2006–2020)
Registration
Form S-1, first filed 2013-07-09, last 2013-08-06; 1 initial registration, 2 amendments
Outcome
Final prospectus filed 2013-08-08; declared effective 2013-08-07
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
VA
Business address
20374 SENECA MEADOWS PARKWAY, Germantown, MD 20876
Ticker
PGEN (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
PRECIGEN, INC. on the corporate pages

Offering terms

Final price
$16.00 per share (424B4 filed 2013-08-08, an initial public offering)
Shares sold
9,999,999
Gross proceeds
$159,999,984 before underwriting discounts and any over-allotment option
Listing
NYSE under the symbol XON
Lead underwriters
J.P. Morgan; Barclays
Syndicate
Griffin Securities; Mizuho

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 7

FiledFormWhat it isName as filedEDGAR
2013-07-09S-1S-1 (registration)INTREXON CORP0001193125-13-286029 ↗
2013-07-29S-1/AS-1/A (amendment)INTREXON CORP0001193125-13-307597 ↗
2013-08-06S-1/AS-1/A (amendment)INTREXON CORP0001193125-13-321136 ↗
2013-08-07S-1MEFS-1MEF (added securities)INTREXON CORP0001193125-13-324807 ↗
2013-08-07EFFECTEFFECT (declared effective)INTREXON CORP9999999995-13-002342 ↗
2013-08-08424B4424B4 (final prospectus)INTREXON CORP0001193125-13-325366 ↗
2014-02-11EFFECTEFFECT (declared effective)INTREXON CORP9999999995-14-000414 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2013-08-06S-1/Aregistration statement$0.795,250,083$4,147,5650primary document; price sentence, shares headline, proceeds computeddocument ↗
2013-08-08424B4final prospectus$16.009,999,999$159,999,984NYSE XON4primary document; price sentence, shares headline, proceeds table, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ALVAREZ CESAR LDirector342013–2026
Broder SamuelOfficerEVP-Scientific & Pub. Affairs; SVP, Head of Health Sector; SVP--Health Sector42013–2015
Frank StevenDirector332013–2026
HORNER LARRY D /FADirector112013–2015
Kasser Thomas R.OfficerSVP--Food Sector42013–2014
KINDLER JEFFREY BDirector352013–2026
KIRK RANDAL JDirector,Officer,TenPercentOwner; Director,TenPercentOwnerChief Executive Officer; Executive Chairman1252013–2026
Krishnan Krish SOfficerChief Operating Officer62013–2016
Krishnan SumaOfficerSVP--Product Development; SVP--Regulatory Affairs62013–2016
Lehr Donald P.OfficerChief Legal Officer512013–2026
Macris NickOfficerVP--Environmental Sector12013
MITCHELL DEAN JDirector; Director,TenPercentOwner262013–2024
Reed Thomas D.Director,Officer; OfficerChief Science Officer192013–2020
SHAPIRO ROBERT BDirector242013–2023person page Fuzzy
Sterling Rick L.Director,Officer; OfficerChief Financial Officer232013–2021
Walsh Robert F. IIIOfficerSVP, Energy & Fine Chem.; SVP-Energy; Pres.-Indus Prods; SVP, Methanotroph & Fine Chem.92013–2019
Webster DarrylOfficerSVP--Intellectual Property32013–2014
Frost Gregory IanOfficerSVP--Health Sector42014–2015
Huang KellyOfficerSVP-Consumer Sector32014
Nimrodi NirOfficerChief Business Officer; SVP-Corporate Development; SVP-Environment Sector72014–2019
Turley James SDirector212014–2026
Perez Jeffrey ThomasOfficerSVP, IP Affairs422014–2024
Jarry Olivier R.OfficerSVP--Consumer Sector22015
Bobo Jack AOfficerSVP, Chief Communications Off.22015
LIFFMAN JOEL DOfficerSVP, Finance72015–2019
Huck CoreyOfficerSVP, Food Sector22015
VAILLANCOURT JOSEPH LOfficerSVP, Environment Sector22015
INTREXON CORPOfficer; OtherSVP, Consumer Sector32016
Cratsenburg Ena ChanOfficerSVP, Consumer Sector22016
Germano Geno JOfficerPresident42016person page Fuzzy
Hassan FredDirector212016–2026
Last Andrew J.OfficerChief Operating Officer42016–2017
Gupta Vinita DDirector192017–2026
Bostick ThomasOfficerChief Operating Officer112017–2020
Sabzevari HelenDirector,Officer; OfficerPresident and CEO; President, Precigen, Inc.512017–2026
Ares Trading S.A.Director; TenPercentOwner382019–2021
Merck KGaATenPercentOwner12019
MERCK SERONO S.A.TenPercentOwner12019
Osborne D. BradfordOfficerVP, Finance and Accounting22021
Lambert James VincentOfficerEx. Dir. Fin., PGEN Ther. Inc.12021
Thomasian Harry Jr.OfficerChief Financial Office; Chief Financial Officer312021–2026
Shah Rutul ROfficerChief Operating Officer252022–2026
AGEE NANCY HDirector92024–2026
Tennant PhilOfficerChief Commercial Officer142024–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2020-12-17PRECIGEN, INC.Pharmaceuticals$13,000,000$13,000,00021
2020-02-11PRECIGEN, INC.Biotechnology$35,000,000$35,000,00011
2016-03-09INTREXON CORPBiotechnology$4,250,000$4,250,00021
2015-09-21INTREXON CORPBiotechnology$21,585,401$21,585,401201
2015-03-11INTREXON CORPBiotechnology$450,015$450,01511
2015-03-09INTREXON CORPBiotechnology$10,196,546$10,196,546781
2015-01-28INTREXON CORPBiotechnology$57,500,000$57,500,00011
2014-08-22INTREXON CORPBiotechnology$28,634,166$28,634,16651
2014-04-10INTREXON CORPBiotechnology$24,999,943$24,999,94351
2012-01-09INTREXON CORPBiotechnology$50,000,003$50,000,003422

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationPrecigen, Inc.MDState business registriesname and state
Business registrationPrecigen, Inc.MDState business registriesname and state
Business registrationPrecigen, Inc.MDState business registriesname and state
Business registrationPRECIGEN, Inc.MDState business registriesname and state
Business registrationPRECIGEN, INC.MDState business registriesname and state
Business registrationPRECIGEN, INC.MDState business registriesname and state
Business registrationPRECIGEN, INC.MDState business registriesname and state
Business registrationPRECIGEN, INC.MDState business registriesname and state
Business registrationPRECIGEN, INC.MDState business registriesname and state
Business registrationPRECIGEN, INC.MDState business registriesname and state
Business registrationPRECIGEN, INC.MDState business registriesname and state
Federal award recipientPRECIGEN INCMDFederal spending (USAspending)name and state
Form D issuerPRECIGEN, INC.MDForm D private offeringsCIK (EXACT)
Paying companyPRECIGEN, INC.MDOpen Payments (drug and device company payments)name and state
Patent assigneePrecigen, Inc.MDPatents (USPTO)name and state
SEC filerPRECIGEN, INC.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerPrecigen, Inc.MDTrademarks (USPTO)name and state
Person pageGeno J GermanoPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer)
Person pageRobert B ShapiroPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, MD first:

More with this interest.

In other datasets, the same topic (Health) in MD:

Interests: Pharmaceutical Preparations · Health